Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
American Journal of Medical Genetics. Part A|November 7, 2015
Microdeletion del(22)(q12.1) excluding the MN1 gene in a patient with craniofacial anomaliesCaroline Bosson, Françoise Devillard, Véronique Satre, et al.
Cancer Genetics and Cytogenetics|September 25, 2007
Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosisJoris Andrieux, Catherine Roche-Lestienne, Sandrine Geffroy, et al.
American Journal of Medical Genetics. Part A|June 26, 2010
Syndromic mental retardation with thrombocytopenia due to 21q22.11q22.12 deletion: Report of three patientsEleni Katzaki, Gilles Morin, Marzia Pollazzon, et al.
European Journal of Human Genetics : EJHG|February 21, 2013
Extended spectrum of MBD5 mutations in neurodevelopmental disordersCéline Bonnet, Asma Ali Khan, Emmanuel Bresso, et al.
European Journal of Haematology|August 19, 2007
Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage IThomas Gastinne, Xavier Leleu, Alain Duhamel, et al.
American Journal of Medical Genetics. Part A|April 24, 2013
Clinical comparison of overlapping deletions of 19p13.3Hiba Risheg, Romela Pasion, Stephanie Sacharow, et al.
American Journal of Medical Genetics. Part A|June 10, 2017
Clinical and molecular cytogenetic characterization of four unrelated patients carrying 2p14 microdeletionsMarie-Laure Mathieu, Caroline Demily, Sandra Chantot-Bastaraud, et al.
European Journal of Medical Genetics|October 29, 2013
Involvement of germline DDX1-MYCN duplication in inherited nephroblastomaAlice Fievet, Marc-Antoine Belaud-Rotureau, Frédéric Dugay, et al.
American Journal of Human Genetics|August 30, 2016
Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex FamiliesVirpi M Leppa, Stephanie N Kravitz, Christa Lese Martin, et al.
Stem Cells (Dayton, Ohio)|January 29, 2013
The PI3K/AKT signaling pathway controls the quiescence of the low-Rhodamine123-retention cell compartment enriched for melanoma stem cell activityYasmine Touil, Thomas Zuliani, Isabelle Wolowczuk, et al.
Pageof 13